4D Lifetec is at the forefront of revolutionizing early cancer detection through its innovative product, the 4D Lifetest™. This non-invasive blood test utilizes a proprietary biomarker known as DDS (DNA Damage Sensitivity) to accurately quantify DNA fragmentation in blood cells, enabling the detection of various types of cancer at their earliest stages (I and II). The test is designed to be user-friendly for healthcare professionals and is supported by strong clinical evidence, including multiple publications and extensive patient data from regions such as Switzerland, the EU, and the US. By focusing on early detection, 4D Lifetest™ aims to provide patients with timely intervention options, significantly improving their chances of successful treatment and recovery.

In addition to its groundbreaking testing capabilities, 4D Lifetec emphasizes the integration of advanced artificial intelligence (AI) to enhance the accuracy and efficiency of its diagnostic processes. The company is actively collaborating with renowned cancer centers to validate the effectiveness of the 4D Lifetest™ across various cancer types, including breast, lung, prostate, and colon cancers. With a robust intellectual property strategy that includes patents in key global markets, 4D Lifetec is committed to maintaining its competitive edge in the field of cancer diagnostics, ultimately striving to empower lives through early detection and improved patient outcomes.

Switzerland

About 4D Lifetec AG
4D Lifetec is a pioneer on a mission to revolutionize early cancer detection. Our easy and powerful blood tests can detect cancer at its earliest stages (I and II), offering you peace of mind and proactive well-being protection. Sophisticated artificial intelligence (AI) enhances our immunological high-throughput blood assays which in turn enables timely intervention and treatment.

4D Lifetec

Company Details